Improve Medical Instruments Co., Ltd. (300030.SZ)
CNY 5.65
(0.36%)
CNY 5.65
(0.36%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 17.73 Million CNY | 331.84% |
| 2022 | -19.68 Million CNY | -114.45% |
| 2021 | 102.59 Million CNY | -53.48% |
| 2020 | 227.25 Million CNY | 178.85% |
| 2019 | 99.32 Million CNY | 123.59% |
| 2018 | -71.29 Million CNY | -50.72% |
| 2017 | 81.21 Million CNY | -2.67% |
| 2016 | 99.37 Million CNY | -0.43% |
| 2015 | 95.43 Million CNY | 2.99% |
| 2014 | 100.23 Million CNY | 14.56% |
| 2013 | 83.49 Million CNY | 26.33% |
| 2012 | 66.22 Million CNY | 17.28% |
| 2011 | 56.45 Million CNY | 39.58% |
| 2010 | 43.75 Million CNY | 11.62% |
| 2009 | 36.64 Million CNY | 27.35% |
| 2008 | 28.2 Million CNY | 72.81% |
| 2007 | 16.88 Million CNY | 37.55% |
| 2006 | 11.7 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 14.33 Million CNY | 3015.12% |
| 2024 Q1 | -152.65 Thousand CNY | 101.47% |
| 2024 Q3 | -35.82 Million CNY | -349.9% |
| 2023 Q4 | -18.8 Million CNY | -582.91% |
| 2023 Q3 | -2.75 Million CNY | -271.56% |
| 2023 Q2 | 1.6 Million CNY | -92.16% |
| 2023 FY | - CNY | 331.84% |
| 2023 Q1 | 20.47 Million CNY | 162.33% |
| 2022 Q1 | -28.92 Million CNY | -275.67% |
| 2022 FY | - CNY | -114.45% |
| 2022 Q4 | -32.84 Million CNY | -104.12% |
| 2022 Q3 | -16.08 Million CNY | -240.95% |
| 2022 Q2 | 11.41 Million CNY | 139.47% |
| 2021 Q2 | 72.47 Million CNY | 58.56% |
| 2021 Q1 | 45.71 Million CNY | 2494.2% |
| 2021 Q3 | -51.72 Million CNY | -171.37% |
| 2021 FY | - CNY | -53.48% |
| 2021 Q4 | 16.46 Million CNY | 131.83% |
| 2020 Q3 | 116.63 Million CNY | 0.18% |
| 2020 Q2 | 116.42 Million CNY | 465.58% |
| 2020 Q1 | 20.58 Million CNY | 78.55% |
| 2020 FY | - CNY | 178.85% |
| 2020 Q4 | 1.76 Million CNY | -98.49% |
| 2019 Q2 | 22.4 Million CNY | 55.28% |
| 2019 FY | - CNY | 123.59% |
| 2019 Q1 | 14.42 Million CNY | 147.68% |
| 2019 Q3 | 17.62 Million CNY | -21.34% |
| 2019 Q4 | 11.52 Million CNY | -34.57% |
| 2018 Q4 | -30.25 Million CNY | -443.3% |
| 2018 Q1 | 16.22 Million CNY | 7.92% |
| 2018 FY | - CNY | -50.72% |
| 2018 Q3 | 8.81 Million CNY | -37.11% |
| 2018 Q2 | 14.01 Million CNY | -13.62% |
| 2017 Q2 | 17.95 Million CNY | 46.9% |
| 2017 FY | - CNY | -2.67% |
| 2017 Q4 | 15.03 Million CNY | 19.15% |
| 2017 Q3 | 12.61 Million CNY | -29.73% |
| 2017 Q1 | 12.22 Million CNY | -60.33% |
| 2016 Q4 | 30.81 Million CNY | 229.92% |
| 2016 Q1 | 6.75 Million CNY | -74.05% |
| 2016 FY | - CNY | -0.43% |
| 2016 Q2 | 20.03 Million CNY | 196.64% |
| 2016 Q3 | 9.33 Million CNY | -53.38% |
| 2015 Q2 | 20.2 Million CNY | 92.89% |
| 2015 Q4 | 26.02 Million CNY | 123.01% |
| 2015 Q3 | 11.66 Million CNY | -42.25% |
| 2015 FY | - CNY | 2.99% |
| 2015 Q1 | 10.47 Million CNY | -67.13% |
| 2014 Q1 | 2.83 Million CNY | -92.86% |
| 2014 Q2 | 20.16 Million CNY | 611.78% |
| 2014 Q3 | 22.29 Million CNY | 10.55% |
| 2014 Q4 | 31.87 Million CNY | 42.97% |
| 2014 FY | - CNY | 14.56% |
| 2013 Q3 | 10.09 Million CNY | 6.58% |
| 2013 Q1 | 1.84 Million CNY | -93.5% |
| 2013 Q2 | 9.47 Million CNY | 411.95% |
| 2013 FY | - CNY | 26.33% |
| 2013 Q4 | 39.66 Million CNY | 293.01% |
| 2012 Q1 | 5.34 Million CNY | -76.42% |
| 2012 Q2 | 7.47 Million CNY | 39.89% |
| 2012 Q3 | 7.08 Million CNY | -5.25% |
| 2012 Q4 | 28.46 Million CNY | 301.81% |
| 2012 FY | - CNY | 17.28% |
| 2011 FY | - CNY | 39.58% |
| 2011 Q1 | 2.82 Million CNY | -84.23% |
| 2011 Q2 | 9.67 Million CNY | 242.4% |
| 2011 Q3 | 11.52 Million CNY | 19.08% |
| 2011 Q4 | 22.66 Million CNY | 96.65% |
| 2010 Q3 | 7.1 Million CNY | -6.45% |
| 2010 Q2 | 7.59 Million CNY | 503.02% |
| 2010 Q1 | 1.26 Million CNY | -88.05% |
| 2010 Q4 | 17.92 Million CNY | 152.21% |
| 2010 FY | - CNY | 11.62% |
| 2009 Q1 | 2.57 Million CNY | -76.69% |
| 2009 Q3 | 8.13 Million CNY | -26.57% |
| 2009 Q4 | 10.54 Million CNY | 29.58% |
| 2009 FY | - CNY | 27.35% |
| 2009 Q2 | 11.07 Million CNY | 330.07% |
| 2008 Q3 | 6.13 Million CNY | 0.0% |
| 2008 Q4 | 11.05 Million CNY | 80.19% |
| 2008 FY | - CNY | 72.81% |
| 2007 FY | - CNY | 37.55% |
| 2006 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 3.15 Billion CNY | 99.437% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 1.05 Billion CNY | 98.312% |
| Blue Sail Medical Co.,Ltd. | 132.74 Million CNY | 86.637% |
| Andon Health Co., Ltd. | 1.69 Billion CNY | 98.955% |
| Allmed Medical Products Co., Ltd | 409.86 Million CNY | 95.672% |
| Tofflon Science and Technology Group Co., Ltd. | 826.99 Million CNY | 97.855% |
| Truking Technology Limited | 585.49 Million CNY | 96.97% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 336.13 Million CNY | 94.723% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 357.94 Million CNY | 95.044% |
| Autek China Inc. | 965.74 Million CNY | 98.163% |
| Intco Medical Technology Co., Ltd. | 1.16 Billion CNY | 98.479% |
| Jiangsu Apon Medical Technology Co., Ltd. | 41.9 Million CNY | 57.673% |
| Winner Medical Co., Ltd. | 1.4 Billion CNY | 98.74% |
| Imeik Technology Development Co.,Ltd. | 2.2 Billion CNY | 99.195% |
| Zhonghong Pulin Medical Products Co., Ltd. | 86.58 Million CNY | 79.513% |
| Caina Technology Co., Ltd. | 161.95 Million CNY | 89.048% |